# GTF2F2

## Overview
GTF2F2, or general transcription factor IIF subunit 2, is a gene that encodes a protein integral to the transcription factor IIF (TFIIF) complex, which is essential for the transcription process mediated by RNA polymerase II. The protein encoded by GTF2F2 is a nuclear factor that plays a pivotal role in both the initiation and elongation phases of transcription, facilitating the recruitment and stabilization of RNA polymerase II at gene promoters. As a component of the TFIIF complex, GTF2F2 forms a heterodimer with GTF2F1, contributing to the regulation of gene expression and mRNA synthesis. This protein is involved in various cellular processes, including neurogenesis and immune response pathways, highlighting its significance in maintaining normal cellular functions and organismal development (Cojocaru2007Genomic; Zhang2022General).

## Function
GTF2F2, also known as general transcription factor IIF subunit 2, is a crucial component of the transcription factor IIF (TFIIF) complex, which plays a significant role in the transcription process mediated by RNA polymerase II. In healthy human cells, GTF2F2 is involved in both the initiation and elongation phases of transcription. It forms a heterodimer with GTF2F1, facilitating the recruitment of RNA polymerase II to gene promoters and stabilizing the transcription pre-initiation complex (Cojocaru2007Genomic; Zhang2022General).

GTF2F2 is active in the cell nucleus, where it binds to RNA polymerase II, promoting transcription elongation by assisting in promoter escape and reducing polymerase pausing. This activity is essential for efficient mRNA synthesis and gene expression regulation (Cojocaru2007Genomic; Wu2015Bioinformatics). The protein is also implicated in various cellular processes, including neurogenesis, neuroplasticity, and synaptogenesis, through its interaction with Nuclear respiratory factor-1 (NRF-1) (Zhang2022General).

The involvement of GTF2F2 in these molecular processes underscores its importance in maintaining normal cellular functions and organismal development, impacting pathways related to immune response and energy metabolism (Zhang2022General).

## Clinical Significance
The GTF2F2 gene has been implicated in several diseases and conditions due to its role in transcription regulation and its interactions with various signaling pathways. In the context of major depressive disorder (MDD), GTF2F2 is identified as a hub gene with significant upregulation in depression samples. It is involved in pathways such as JAK-STAT, PI3K-Akt, and TGF-β, which are associated with the pathophysiology of MDD (Zhang2022General). Alterations in GTF2F2 expression levels are linked to immune response regulation, affecting the serotonin system and potentially exerting anti-depressive effects (Zhang2022General).

GTF2F2 is also associated with neurogenesis, neuroplasticity, and synaptogenesis, processes that are crucial in maintaining normal brain function and are often disrupted in depression (Zhang2022General). Dysregulation of GTF2F2 has been observed in other conditions such as Alzheimer's disease and diabetes mellitus, indicating its broader clinical significance beyond depression (Zhang2022General). While specific mutations in GTF2F2 are not detailed in the context, its dysregulation in these diseases suggests that alterations in its expression or interactions could contribute to their pathogenesis.

## Interactions
GTF2F2, also known as General Transcription Factor IIF subunit 2, is a component of the TFIIF complex, which plays a crucial role in the initiation and elongation phases of transcription by RNA polymerase II. GTF2F2 forms a heterodimer with GTF2F1, and this complex is essential for the proper functioning of RNA polymerase II during transcription (Minchenko2016Hypoxic; Sasaki2013Variants). 

GTF2F2 interacts with several proteins involved in transcription regulation. It is part of a complex that includes MYC, CDK9, and RNA polymerase II, indicating its role in transcription elongation (Kalkat2018MYC). The interaction between MYC and the TFIIF heterodimer, which includes GTF2F2, has been confirmed through techniques such as proximity ligation assays and biolayer interferometry (Kalkat2018MYC). 

GTF2F2 is also involved in various biological signaling pathways, including those related to the immune response, such as the JAK-STAT and PI3K-Akt pathways (Zhang2022General). These interactions highlight the multifaceted role of GTF2F2 in transcriptional regulation and its potential impact on various physiological and pathological processes.


## References


[1. (Zhang2022General) Chi Zhang, Min Cheng, Naifu Dong, Dongjie Sun, and Haichun Ma. General transcription factor iif polypeptide 2: a novel therapeutic target for depression identified using an integrated bioinformatic analysis. Frontiers in Aging Neuroscience, May 2022. URL: http://dx.doi.org/10.3389/fnagi.2022.918217, doi:10.3389/fnagi.2022.918217. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnagi.2022.918217)

[2. (Sasaki2013Variants) Shinji Sasaki, Takayuki Ibi, Toshio Watanabe, Tamako Matsuhashi, Shogo Ikeda, and Yoshikazu Sugimoto. Variants in the 3’ utr of general transcription factor iif, polypeptide 2 affect female calving efficiency in japanese black cattle. BMC Genetics, 14(1):41, 2013. URL: http://dx.doi.org/10.1186/1471-2156-14-41, doi:10.1186/1471-2156-14-41. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2156-14-41)

[3. (Wu2015Bioinformatics) Yanfeng Wu, Peng Xia, and Changjun Zheng. Bioinformatics analysis of transcription profiling of sepsis. European Journal of Inflammation, 13(2):82–90, June 2015. URL: http://dx.doi.org/10.1177/1721727X15590946, doi:10.1177/1721727x15590946. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1721727X15590946)

[4. (Cojocaru2007Genomic) Marilena Cojocaru, Célia Jeronimo, Diane Forget, Annie Bouchard, Dominique Bergeron, Pierre Côte, Guy G. Poirier, Jack Greenblatt, and Benoit Coulombe. Genomic location of the human rna polymerase ii general machinery: evidence for a role of tfiif and rpb7 at both early and late stages of transcription. Biochemical Journal, 409(1):139–147, December 2007. URL: http://dx.doi.org/10.1042/bj20070751, doi:10.1042/bj20070751. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20070751)

[5. (Minchenko2016Hypoxic) O. H. Minchenko, D. O. Tsymbal, D. O. Minchenko, and O. O. Kubaychuk. Hypoxic regulation of mybl1, mest, tcf3, tcf8, gtf2b, gtf2f2 and snai2 genes expression in u87 glioma cells upon ire1 inhibition. The Ukrainian Biochemical Journal, 88(6):52–62, December 2016. URL: http://dx.doi.org/10.15407/ubj88.06.052, doi:10.15407/ubj88.06.052. This article has 5 citations.](https://doi.org/10.15407/ubj88.06.052)

[6. (Kalkat2018MYC) Manpreet Kalkat, Diana Resetca, Corey Lourenco, Pak-Kei Chan, Yong Wei, Yu-Jia Shiah, Natasha Vitkin, Yufeng Tong, Maria Sunnerhagen, Susan J. Done, Paul C. Boutros, Brian Raught, and Linda Z. Penn. Myc protein interactome profiling reveals functionally distinct regions that cooperate to drive tumorigenesis. Molecular Cell, 72(5):836-848.e7, December 2018. URL: http://dx.doi.org/10.1016/j.molcel.2018.09.031, doi:10.1016/j.molcel.2018.09.031. This article has 138 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2018.09.031)